Lassen MR - Search Results

1

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

Turpie AG, Bauer KA, Eriksson BI, Lassen MR; PENTATHALON 2000 Study Steering Committee. Turpie AG, et al. Among authors: lassen mr. Lancet. 2002 May 18;359(9319):1721-6. doi: 10.1016/S0140-6736(02)08648-8. Lancet. 2002. PMID: 12049860 Clinical Trial.

2

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Turpie AG, et al. Among authors: lassen mr. Arch Intern Med. 2002 Sep 9;162(16):1833-40. doi: 10.1001/archinte.162.16.1833. Arch Intern Med. 2002. PMID: 12196081

3

A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.

Turpie AG, Eriksson BI, Lassen MR, Bauer KA. Turpie AG, et al. Among authors: lassen mr. J South Orthop Assoc. 2002 Winter;11(4):182-8. J South Orthop Assoc. 2002. PMID: 12597061 Clinical Trial.

4

Fondaparinux, the first selective factor Xa inhibitor.

Turpie AG, Eriksson BI, Lassen MR, Bauer KA. Turpie AG, et al. Among authors: lassen mr. Curr Opin Hematol. 2003 Sep;10(5):327-32. doi: 10.1097/00062752-200309000-00001. Curr Opin Hematol. 2003. PMID: 12913785 Review.

5

Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Turpie AG, et al. Among authors: lassen mr. Lancet. 2003 Nov 8;362(9395):1582-3. doi: 10.1016/S0140-6736(03)14753-8. Lancet. 2003. PMID: 14615120 No abstract available.

6

New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.

Turpie AG, Eriksson BI, Bauer KA, Lassen MR. Turpie AG, et al. Among authors: lassen mr. Chest. 2003 Dec;124(6 Suppl):371S-378S. Chest. 2003. PMID: 14668420 Review.

7

Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Turpie AG, et al. Among authors: lassen mr. Chest. 2004 Aug;126(2):501-8. doi: 10.1378/chest.126.2.501. Chest. 2004. PMID: 15302737 Clinical Trial.

8

Fondaparinux.

Turpie AG, Eriksson BI, Bauer KA, Lassen MR. Turpie AG, et al. Among authors: lassen mr. J Am Acad Orthop Surg. 2004 Nov-Dec;12(6):371-5. doi: 10.5435/00124635-200411000-00001. J Am Acad Orthop Surg. 2004. PMID: 15615502 Review. No abstract available.

9

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators. Turpie AG, et al. Among authors: lassen mr. Lancet. 2009 May 16;373(9676):1673-80. doi: 10.1016/S0140-6736(09)60734-0. Epub 2009 May 4. Lancet. 2009. PMID: 19411100 Clinical Trial.

10

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.

Lassen MR, Bauer KA, Eriksson BI, Turpie AG; European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Lassen MR, et al. Lancet. 2002 May 18;359(9319):1715-20. doi: 10.1016/S0140-6736(02)08652-X. Lancet. 2002. PMID: 12049858 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page